Old Web
How should we assess the clinical and cost effectiveness of histology independent cancer drugs
2020
Sophie Cooper, Jacoline Bouvy and colleagues discuss the challenges that histology independent cancer drugs will pose for NICE and the NHS
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
7
References
5
Citations
NaN
KQI